Generate Biomedicines (GENB)'s 30-day implied volatility (IV30) was 78.7% at the close on October 22, 2026, up from 73.5% the day before, against a 52-week range of 68.4% to 82.6%. Its 20-day historical volatility was 73.3%.
Data as of October 22, 2026.